During the past decade, Hospital de Mataró conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 12 clinical trials were completed, i.e. on average, 35.3% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 6 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital de Mataró" #1 sponsor was "Hospital de Mataró" with 7 trials, followed by "Fundacion SEIMC-GESIDA" with 4 trials sponsored, "Germans Trias i Pujol Hospital" with 4 trials sponsored, "Spanish Lung Cancer Group" with 4 trials sponsored and "PETHEMA Foundation" with 4 trials sponsored. Other sponsors include 37 different institutions and companies that sponsored additional 42 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital de Mataró" #1 collaborator was "ETOP IBCSG Partners Foundation" with 2 trials as a collaborator, "Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia" with 2 trials as a collaborator, "Hospital de Granollers" with 2 trials as a collaborator, "Hospital de Mataró" with 2 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 39 trials.

According to Clinical.Site data, the most researched conditions in "Hospital de Mataró" are "Dysphagia" (4 trials), "HIV Infections" (4 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Chronic Postoperative Pain" (2 trials) and "Covid19" (2 trials). Many other conditions were trialed in "Hospital de Mataró" in a lesser frequency.

Most popular intervention types in "Hospital de Mataró" are "Drug" (39 trials), "Device" (6 trials), "Other" (5 trials), "Procedure" (5 trials) and "Behavioral" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Carboplatin" (4 trials), "Cisplatin" (4 trials), "Docetaxel" (4 trials) and "Paclitaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hospital de Mataró" are 57 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital de Mataró". undefined are not yet recruiting, 10 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 43 completed trials in Hospital de Mataró, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital de Mataró, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 12 trials, and there were also 8 trials that are defined as “Not Applicable".